Robaxin and Loss of consciousness - a phase IV clinical study of FDA data
Loss of consciousness is found among people who take Robaxin, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Robaxin and have Loss of consciousness. It is created by eHealthMe based on reports of 7,061 people who have side effects when taking Robaxin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,061 people reported to have side effects when taking Robaxin.
Among them, 133 people (1.88%) have Loss of consciousness.
What is Robaxin?
Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 7,882 Robaxin users for its effectiveness, alternative drugs and more.
What is Loss of consciousness?
Loss of consciousness is found to be associated with 3,085 drugs and 2,884 conditions by eHealthMe.
Number of Robaxin and Loss of consciousness reports submitted per year:
Time on Robaxin when people have Loss of consciousness *:
Gender of people who have Loss of consciousness when taking Robaxin*:
Age of people who have Loss of consciousness when taking Robaxin *:
Common drugs people take besides Robaxin *:
Common side effects people have besides Loss of consciousness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Robaxin and have Loss of consciousness?Check whether Loss of consciousness is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Loss of consciousness and when was it recovered:
Expand to all the drugs that have ingredients of methocarbamol:
Alternative drugs to, pros and cons of Robaxin:
- Robaxin (7,882 reports)
Common Robaxin side effects:
Browse all side effects of Robaxin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Loss of consciousness treatments and more:
- Loss of consciousness (127,028 reports)
COVID vaccines that are related to Loss of consciousness:
- Loss of consciousness in Moderna COVID Vaccine
- Loss of consciousness in Pfizer BioNTech Covid Vaccine
- Loss of consciousness in Johnson and Johnson Covid Vaccine
Common drugs associated with Loss of consciousness:
All the drugs that are associated with Loss of consciousness:
- Loss of consciousness (3,085 drugs)
Common conditions associated with Loss of consciousness:
All the conditions that are associated with Loss of consciousness:
- Loss of consciousness (2,884 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hepatic Cirrhosis and Type 1 Diabetes - 5 seconds ago
- Gastroesophageal Reflux Disease and Drug-Induced Liver Injury - 6 seconds ago
- Quinapril and Retinopathy Hypertensive - 11 seconds ago
- Flatulence and Septic Shock - 15 seconds ago
- Prednisone and Rectal Cancer - 31 seconds ago
- Slow-K and Apixaban drug interaction - 50 seconds ago
- Vitamin D vs. Lodine - 54 seconds ago
- Marplan vs. Valproic Acid - a minute ago
- Chemotherapy and Macular Degeneration - a minute ago
- Augmentin '500' and Restless Leg Syndrome - a minute ago